No standard is perfect, and monograph 0478 has limitations. Critics note that it focuses primarily on quality control at the end of production, rather than on process analytical technology (PAT) or real-time release. Moreover, for complex tablets (e.g., modified-release, multilayer, or paediatric mini-tablets), additional monographs or supplementary tests are required. Some argue that the disintegration test is outdated for modern immediate-release formulations, as dissolution testing alone could suffice. Nevertheless, the monograph’s periodic revision process (each new edition every 3–4 years) allows these concerns to be addressed over time.
#Pharmaceuticals #PhEur #QualityControl #TabletManufacturing #RegulatoryCompliance #Pharmacopoeia european pharmacopoeia ph eur monograph tablets 0478 better